trans-2-tetradecenoyl-l-carnitine function Carnitine-Acylcarnitine Translocase - an overview trans-2-Tetradecenoyl-L-carnitine-(N-methyl-d3) analytical standard | Sigma-Aldrich
Description
MARS also achieved decreases in plasma bilirubin, ammonia and creatinine concentrations as well as improved portal pressure in ACLF [79]

Approximately 20% of cases (n=199) did not have information on tumor grade

Ethical Approval The trial protocol was according to the Declaration of Helsinki as revised in 1989, and the study protocol was approved by the research and ethics committee at Hamadan University of Medical Sciences (IR.UMSHA.REC.1396.873)

The number and percentage of subjects alive at 24 months after baseline were calculated and compared between treatment groups using the chi-square test

Lin H, Lu JP, Laflamme P, Qiao S, Shayegan B, Bryskin I et al
